HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $27 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Dynavax Technologies (NASDAQ:DVAX) and maintained a price target of $27.
August 04, 2023 | 3:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Dynavax Technologies (NASDAQ:DVAX) has been reiterated with a 'Buy' rating by HC Wainwright & Co. The price target remains at $27.
The reiteration of a 'Buy' rating and maintenance of a $27 price target by HC Wainwright & Co. indicates a positive outlook for Dynavax Technologies. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100